Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arthritis Rheum ; 48(12): 3557-67, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14674009

ABSTRACT

OBJECTIVE: To investigate the role of the spleen in the pathogenesis of streptococcal cell wall (SCW)-induced arthritis and determine the impact of splenectomy on monocytes and T cells involved in the arthritis. METHODS: Female Lewis rats were separated into 4 groups: 1) saline-injected, sham-operated; 2) saline-injected, splenectomized; 3) peptidoglycan-polysaccharide (PG-PS)-injected, sham-operated; and 4) PG-PS-injected, splenectomized. After a 10-day recovery period, rats received a single intraperitoneal injection of saline or PG-PS (25 microg rhamnose/gm body weight). We evaluated the effect of splenectomy on joint inflammation, histopathology, leukocyte subtypes in blood and lymph nodes, cytokines, and cell surface expression of CD44 and CD45RC in the chronic phase of the disease (day 28). RESULTS: Splenectomy dramatically decreased chronic joint inflammation and histopathologic damage as well as altered cell types in lymph nodes and peripheral blood, as analyzed by flow cytometry. Nitric oxide (NO) production, levels of interleukin-1beta (IL-1beta), IL-6, tumor necrosis factor alpha, and a biomarker of Th1 cell predominance correlated with the level of joint inflammation. Surprisingly, in splenectomized animals, increased expression of adhesion molecules thought to track T cells to inflamed tissue were observed in lymph nodes. CONCLUSION: The result of splenectomy was attenuation of SCW-induced arthritis and changes in mediators of inflammation, including T cell subsets, proinflammatory cytokines, and NO production. Splenectomy may remove an important antigen reservoir and alter immune cell activation in the SCW-induced arthritis model.


Subject(s)
Arthritis, Infectious/immunology , Arthritis, Infectious/surgery , Splenectomy , Streptococcal Infections/immunology , Streptococcal Infections/surgery , Animals , Arthritis, Infectious/pathology , Biomarkers , Cell Lineage/immunology , Cell Wall/immunology , Chronic Disease , Cytokines/metabolism , Female , Hyaluronan Receptors/metabolism , Joints/pathology , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymphocyte Activation/immunology , Nitrates/blood , Nitrites/blood , Rats , Rats, Inbred Lew , Spleen/immunology , Spleen/surgery , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism
2.
Inflammation ; 27(2): 59-70, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12797545

ABSTRACT

Rheumatoid arthritis (RA) is a common systemic inflammatory disease thought to be T-helper-1 cell driven, though current controversy involves the relative role of T cells versus other leukocytes. Thus, there is a need for better understanding of the role of various leukocytes and their subsets in RA. Using the streptococcal cell wall (SCW) induced arthritis model, we examined leukocytes isolated from peripheral blood, spleen, and lymph nodes using monoclonal antibodies directed against lineage specific cell surface markers. Activation status of these cells was assessed using CD44 and CD71 as markers. T cells in general, and CD4+ T cells in particular were found to be activated in spleen and lymph nodes. B cells and monocytes in spleen demonstrated increased activation as well. The activation of cells in the myeloid and lymphoid lineages in the chronic phase of arthritis indicates ongoing involvement of innate and cognate immunity. This study quantitates specific changes in B and T lymphocytes, and myeloid cells and is consistent with findings in human RA in which specific antibodies, T cells, and myeloid cells are all implicated in the pathogenesis of RA.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Arthritis/immunology , Lymphocyte Activation/immunology , Lymphoid Tissue/pathology , Peptidoglycan/administration & dosage , Animals , Arthritis/etiology , Arthritis/pathology , Blood Cells/immunology , Disease Models, Animal , Female , Immunophenotyping , Leukocyte Count , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphocyte Subsets , Propionibacterium , Rats , Rats, Inbred Lew , Spleen/immunology , Spleen/pathology , Streptococcus/immunology
3.
Clin Immunol ; 105(3): 351-62, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12498817

ABSTRACT

The streptococcal cell wall model of arthritis in Lewis rats consists of an acute, non-T-cell-dependent initiation phase, followed by a remission and then a chronic, inflammatory T-cell-dependent phase. In this report, we define pertinent changes in the cognate and noncognate immune system of the Lewis rats during various phases of the disease. We examined changes in the population size of various cell types using lineage-specific markers in three different tissues (blood, spleen, and lymph nodes) over 28 days. Our results indicate that the T cell and monocyte populations were significantly altered in PG-PS-treated rats and the activation status of these cells parallel initiation, remission, and chronic phases of joint inflammation. Activation of B cells also increases in certain tissues in the chronic phase of the disease. In summary, our results confirm the involvement of both innate and cognate immunity in the development of arthritis and demonstrate that monocytes, in addition to T cells, play a substantive role in the induction and maintenance of the inflammatory process in this rat model.


Subject(s)
Arthritis, Rheumatoid/immunology , Monocytes/immunology , T-Lymphocytes/immunology , Animals , Arthritis, Experimental/immunology , B-Lymphocytes/immunology , Cell Wall/immunology , Lymph Nodes/immunology , Lymphocyte Activation , Rats , Rats, Inbred Lew , Streptococcus/immunology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...